Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Evaluation of serum HGF and CK18 levels in patients with esophageal cancer.

Kilic-Baygutalp N, Ozturk N, Orsal-Ibisoglu E, Gündogdu B, Ozgeris FB, Bakan N, Bakan E, Kilic AF.

Genet Mol Res. 2016 Aug 29;15(3). doi: 10.4238/gmr.15038583.

PMID:
27706656
2.

Study of CK18 and GDF5 immunoexpression in oral squamous cell carcinoma and their prognostic value.

Afrem MC, CrăiŢoiu Ş, Hîncu MC, Manolea HO, Nicolae V, CrăiŢoiu MM.

Rom J Morphol Embryol. 2016;57(1):167-72.

3.

Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH.

Pimentel CF, Jiang ZG, Otsubo T, Feldbrügge L, Challies TL, Nasser I, Robson S, Afdhal N, Lai M.

Dig Dis Sci. 2016 Mar;61(3):905-12. doi: 10.1007/s10620-015-3916-1. Epub 2015 Oct 13.

4.

Endocrine mucin-producing sweat gland carcinoma: a study of three cases and CK8, CK18 and CD5/6 immunoexpression.

Fernandez-Flores A, Cassarino DS.

J Cutan Pathol. 2015 Aug;42(8):578-86. doi: 10.1111/cup.12512. Epub 2015 Jun 1.

PMID:
25925290
5.

(Cleaved) CK18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allografts.

Reis H, Wohlschläger J, Hagemann S, Wenzel P, Bechmann LP, Suttorp AC, Schlattjan MJ, Herzer K, Canbay A, Baba HA.

Liver Int. 2015 Mar;35(3):905-13. doi: 10.1111/liv.12572. Epub 2014 May 12.

PMID:
24750688
6.

Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study.

Morling JR, Fallowfield JA, Williamson RM, Nee LD, Jackson AP, Glancy S, Reynolds RM, Hayes PC, Guha IN, Strachan MW, Price JF.

Liver Int. 2014 Sep;34(8):1267-77. doi: 10.1111/liv.12385. Epub 2013 Dec 3.

PMID:
24237940
11.

Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer.

Greystoke A, Dean E, Saunders MP, Cummings J, Hughes A, Ranson M, Dive C, Renehan AG.

Br J Cancer. 2012 Oct 23;107(9):1518-24. doi: 10.1038/bjc.2012.416. Epub 2012 Sep 20.

12.

Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: an immunohistochemistry study.

Nanda KD, Ranganathan K, Devi U, Joshua E.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Feb;113(2):245-53. doi: 10.1016/j.tripleo.2011.05.034. Epub 2011 Aug 27.

PMID:
22677743
13.

Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.

Jazwinski AB, Thompson AJ, Clark PJ, Naggie S, Tillmann HL, Patel K.

J Viral Hepat. 2012 Apr;19(4):278-82. doi: 10.1111/j.1365-2893.2011.01546.x. Epub 2011 Nov 24.

14.

A pilot study assessing the prognostic value of CK18 and nDNA biomarkers in severe sepsis patients.

Moore DJ, Greystoke A, Butt F, Wurthner J, Growcott J, Hughes A, Dive C.

Clin Drug Investig. 2012 Mar 1;32(3):179-87. doi: 10.2165/11598610-000000000-00000.

PMID:
22217154
15.
17.

Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD.

Fitzpatrick E, Mitry RR, Quaglia A, Hussain MJ, DeBruyne R, Dhawan A.

J Pediatr Gastroenterol Nutr. 2010 Oct;51(4):500-6. doi: 10.1097/MPG.0b013e3181e376be.

PMID:
20808246
18.

Antibody to cytokeratin (CK8/CK18) is not derived from CAM5.2 clone, and anticytokeratin CAM5.2 (Becton Dickinson) is not synonymous with the antibody (CK8/CK18).

Han CP, Hsu JD, Koo CL, Yang SF.

Hum Pathol. 2010 Apr;41(4):616-7; author reply 617. doi: 10.1016/j.humpath.2010.01.001. No abstract available.

PMID:
20226963
19.

[Relationship between CK18 expression in pathologically negative lymph nodes and Tiam 1 mRNA expression in the gastric cancer tissue].

Xu W, Shan HL, Zhang MW.

Zhonghua Zhong Liu Za Zhi. 2009 Dec;31(12):919-20. Chinese. No abstract available.

PMID:
20193332
20.

Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.

Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Yerci O, Oral AY, Gul CB, Gurel S, Nak SG, Gulten M.

Med Sci Monit. 2009 Apr;15(4):CR189-93.

PMID:
19333204

Supplemental Content

Support Center